The increased severity of PIMS when compared to COVID-19 was also emphasized by the higher likelihood of thromboembolic events due to the significantly elevated D-dimers, but also by the higher chance to develop cardiac impairment based on the significantly higher levels of NT-proBNP and CK-MB in the setting of PIMS. This evidence concerns the gene NPPB and COVID-19.